Enantioselective synthesis of (S)-phenylephrine by whole cells of recombinant Escherichia coli expressing the amino alcohol dehydrogenase gene from Rhodococcus erythropolis BCRC 10909

Process Biochemistry

Volumn 45, Issue 9, 2010, Pages 1529-1536

  Lin, Wei De ^a,b,c   Chen, Chien Yu ^a   Chen, Huei Chung ^a   Hsu, Wen Hwei ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Amino alcohol dehydrogenase; Bioconversion; Enantioselective synthesis; Phenylephrine; Rhodococcus erythropolis

Indexed keywords

AMINO ALCOHOL DEHYDROGENASE; AMINO ALCOHOLS; ENANTIOSELECTIVE SYNTHESIS; PHENYLEPHRINE; RHODOCOCCUS ERYTHROPOLIS;

ALCOHOLS; AMINES; DEHYDROGENATION; ESCHERICHIA COLI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OPTICAL ROTATION;

SYNTHESIS (CHEMICAL);

ESCHERICHIA COLI; RHODOCOCCUS ERYTHROPOLIS;

EID: 77955048908     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2010.06.003     Document Type: Article

References (45)

1. Hanna P.E. Adrenergic agents. Wilson and Gisvold's textbook of organic medicinal and pharmaceutical chemistry 1991, 413-442. Lippincott-Raven, Philadelphia. 9th ed. J.N. Delgado, W.A. Remers (Eds.).
2. Westfall T.C., Westfall D.P. Adrenergic agonists and antagonists. Goodman and Gilman's the pharmacological basis of therapeutics 2006, 237-295. McGraw-Hill, New York. 11th ed. L.L. Brunton, J.S. Lazo, K.L. Parker (Eds.).
3. 3H-phenylephrine in man. Eur J Clin Pharmacol 1982, 21:335-341.
4. Kanfer I., Dowse R., Vuma V. Pharmacokinetics of oral decongestants. Pharmacotherapy 1993, 13:116S-128S.
5. Hoffman B.B. Adrenoceptor-activating and other sympathomimetic drugs. Basic & clinical pharmacology 2007, 121-140. McGraw-Hill, New York. 10th ed. B.G. Katzung (Ed.).
6. Tanne J.H. Methamphetamine epidemic hits middle America. BMJ 2006, 332:382.
7. Coombes R. Cold Turkey. BMJ 2007, 334:1190-1192.
8. Bergmann E.D., Sulzbacher M. A new synthesis of 1-(m- and p-hydroxyphenyl)-2-methylaminoethanol (m- and p-sympathol). J Org Chem 1951, 16:84-89.
9. Russell P.B., Childerss S.T. New route to phenylephrine. J Pharm Sci 1961, 50:713.
10. Britten A.Z. A new route to d,l-phenylephrine. Chem Ind 1968, 24:771-772.
11. R)-MCCPM-rhodium complex. Tetrahedron Lett 1989, 30:367-370.
12. Klinger FD, Wolter L, Dietrich W. Method for preparing of l-phenylephrine hydrochloride. U.S. Patent 6,187,956 (2001).
13. Pandey R.K., Upadhyay P.K., Kumar P. Enantioselective synthesis of (R)-phenylephrine hydrochloride. Tetrahedron Lett 2003, 44:6245-6246.
14. Kumar P., Naidu V., Gupta P. Application of hydrolytic kinetic resolution (HKR) in the synthesis of bioactive compounds. Tetrahedron 2007, 63:2745-2785.
15. De Wildeman S.M., Sonke T., Schoemaker H.E., May O. Biocatalytic reductions: from lab curiosity to " first choice" Acc Chem Res 2007, 40:1260-1266.
16. Kroutil W., Mang H., Edegger K., Faber K. Recent advances in the biocatalytic reduction of ketones and oxidation of sec-alcohols. Curr Opin Chem Biol 2004, 8:120-126.
17. Patel R., Hanson R., Goswami A., Nanduri V., Banerjee A., Donovan M.J., et al. Enzymatic synthesis of chiral intermediates for pharmaceuticals. J Ind Microbiol Biotechnol 2003, 30:252-259.
18. Hsin L.W., Dersch C.M., Baumann M.H., Stafford D., Glowa J.R., Rothman R.B., et al. Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine. J Med Chem 2002, 45:1321-1329.
19. Zhu D., Yang Y., Hua L. Stereoselective enzymatic synthesis of chiral alcohols with the use of a carbonyl reductase from Candida magnoliae with anti-Prelog enantioselectivity. J Org Chem 2006, 71:4202-4205.
20. Lavandera I., Kern A., Ferreira-Silva B., Glieder A., de Wildeman S., Kroutil W. Stereoselective bioreduction of bulky-bulky ketones by a novel ADH from Ralstonia sp. J Org Chem 2008, 73:6003-6005.
21. Itoh N., Matsuda M., Mabuchi M., Dairi T., Wang J. Chiral alcohol production by NADH-dependent phenylacetaldehyde reductase coupled with in situ regeneration of NADH. Eur J Biochem 2002, 269:2394-2402.
22. Uehling D.E., Donaldson K.H., Deaton D.N., Hyman C.E., Sugg E.E., Barrett D.G., et al. Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres. J Med Chem 2002, 45:567-583.
23. Kataoka M., Ishige T., Urano N., Nakamura Y., Sakuradani E., Fukui S., et al. Cloning and expression of the l-1-amino-2-propanol dehydrogenase gene from Rhodococcus erythropolis, and its application to double chiral compound production. Appl Microbiol Biotechnol 2008, 80:597-604.
24. Dorokhova M.I., Smolina N.E., Tikhonova Ya.O., Mikhalev V.A. Inversion of configuration of optically active 1-m-nitrophenyl-2-methylaminoethanols. Pharm Chem J 1974, 8:209-211.
25. Marín A., García E., García A., Barbas C. Validation of a HPLC quantification of acetaminophen, phenylephrine and chlorpheniramine in pharmaceutical formulations: capsules and sachets. J Pharm Biomed Anal 2002, 29:701-714.
26. Ptácek P., Klíma J., Macek J. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of phenylephrine in human plasma and its application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 858:263-268.
27. Armstrong D.W., Lee J.T., Chang L.W. Enantiomeric impurities in chiral catalysts, auxiliaries and synthons used in enantioselective synthesis. Tetrahedron: Asymmetry 1998, 9:2043-2064.
28. Warnke M.M., Mitchell C.R., Rozhkov R.V., Emrich D.E., Larock R.C., Armstrong D.W. Use of native and derivatized cyclodextrin based and macrocyclic glycopeptide based chiral stationary phases for the enantioseparation of pterocarpans by HPLC. J Liq Chromatogr Relat Technol 2005, 28:823-834.
29. Huang K., Breitbach Z.S., Armstrong D.W. Enantiomeric impurities in chiral synthons, catalysts, and auxiliaries: Part 3. Tetrahedron: Asymmetry 2006, 17:2821-2832.
30. Katz M., Frejd T., Hahn-Hägerdal B., Gorwa-Grauslund M.F. Efficient anaerobic whole cell stereoselective bioreduction with recombinant Saccharomyces cerevisiae. Biotechnol Bioeng 2003, 84:573-582.
31. Hsu S.K., Lo H.H., Kao C.H., Lee D.S., Hsu W.H. Enantioselective synthesis of l-homophenylalanine by whole cells of recombinant Escherichia coli expressing l-aminoacylase and N-acylamino acid racemase genes from Deinococcus radiodurans BCRC12827. Biotechnol Prog 2006, 22:1578-1584.
32. Lee Y.C., Chien H.C., Hsu W.H. Production of N-acetyl-d-neuraminic acid by recombinant whole cells expressing Anabaena sp. CH1 N-acetyl-d-glucosamine 2-epimerase and Escherichia coli N-acetyl-d-neuraminic acid lyase. J Biotechnol 2007, 129:453-460.
33. Marín A., Barbas C. LC/MS for the degradation profiling of cough-cold products under forced conditions. J Pharm Biomed Anal 2004, 35:1035-1045.
34. Kataoka M., Kita K., Wada M., Yasohara Y., Hasegawa J., Shimizu S. Novel bioreduction system for the production of chiral alcohols. Appl Microbiol Biotechnol 2003, 62:437-445.
35. Nakamura K., Yamanaka R., Matsuda T., Harada T. Recent developments in asymmetric reduction of ketones with biocatalysts. Tetrahedron: Asymmetry 2003, 14:2659-2681.
36. Tang Y., Lee H.Y., Tang Y., Kim C.Y., Mathews I., Khosla C. Structural and functional studies on SCO1815: a beta-ketoacyl-acyl carrier protein reductase from Streptomyces coelicolor A3(2). Biochemistry 2006, 45:14085-14093.
37. Zaccai N.R., Carter L.G., Berrow N.S., Sainsbury S., Nettleship J.E., Walter T.S., et al. Crystal structure of a 3-oxoacyl-(acylcarrier protein) reductase (BA3989) from Bacillus anthracis at 2.4-Å resolution. Proteins 2008, 70:562-567.
38. Price A.C., Zhang Y.M., Rock C.O., White S.W. Structure of beta-ketoacyl-[acyl carrier protein] reductase from Escherichia coli: negative cooperativity and its structural basis. Biochemistry 2001, 40:12772-12781.
39. Oppermann U., Filling C., Hult M., Shafqat N., Wu X., Lindh M., et al. Short-chain dehydrogenases/reductases (SDR): the 2002 update. Chem Biol Interact 2003, 143-144:247-253.
40. Filling C., Berndt K.D., Benach J., Knapp S., Prozorovski T., Nordling E., et al. Critical residues for structure and catalysis in short-chain dehydrogenases/reductases. J Biol Chem 2002, 277:25677-25684.
41. Schlieben N.H., Niefind K., Müller J., Riebel B., Hummel W., Schomburg D. Atomic resolution structures of R-specific alcohol dehydrogenase from Lactobacillus brevis provide the structural bases of its substrate and cosubstrate specificity. J Mol Biol 2005, 349:801-813.
42. Kavanagh K.L., Jörnvall H., Persson B., Oppermann U. The SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes. Cell Mol Life Sci 2008, 65:3895-3906.
43. Hoffmann F., Maser E. Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily. Drug Metab Rev 2007, 39:87-144.
44. van der Werf M.J., van der Ven C., Barbirato F., Eppink M.H., de Bont J.A., van Berkel W.J. Stereoselective carveol dehydrogenase from Rhodococcus erythropolis DCL14. A novel nicotinoprotein belonging to the short chain dehydrogenase/reductase superfamily. J Biol Chem 1999, 274:26296-26304.
45. Pennacchio A., Pucci B., Secundo F., La Cara F., Rossi M., Raia C.A. Purification and characterization of a novel recombinant highly enantioselective short-chain NAD(H)-dependent alcohol dehydrogenase from Thermus thermophilus. Appl Environ Microbiol 2008, 74:3949-3958.